Hildegard T Greinix
Overview
Explore the profile of Hildegard T Greinix including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
2286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wurm S, Waltersdorfer M, Loindl S, Moritz J, Herzog S, Bachmaier G, et al.
Wien Klin Wochenschr
. 2024 Nov;
PMID: 39527258
Background: Next-generation sequencing (NGS) has recently entered routine acute myeloid leukemia (AML) diagnostics. It is paramount for AML risk stratification and identification of molecular therapeutic targets. Most NGS feasibility and...
2.
Greinix H, Iftikhar R, Chaudhry Q, Ahmed P, Al-Khabori M, Gaziev J, et al.
Hematol Oncol Stem Cell Ther
. 2024 Oct;
17(3):190-199.
PMID: 39412755
The eighth workshop of the Worldwide Network for Blood and Marrow Transplantation (WBMT) was held in Islamabad, Pakistan, from September 22 to 23, 2022, aiming to foster hematopoietic stem cell...
3.
Garderet L, Gras L, Koster L, Baaij L, Hamad N, DSouza A, et al.
Am J Hematol
. 2024 Aug;
99(11):2084-2095.
PMID: 39158218
Autologous hematopoietic cell transplantation (AHCT) is a commonly used treatment in multiple myeloma (MM). However, real-world global demographic and outcome data are scarce. We collected data on baseline characteristics and...
4.
5.
6.
Bojanic I, Worel N, Pacini C, Stary G, Piekarska A, Flinn A, et al.
Front Immunol
. 2023 Mar;
14:1086006.
PMID: 36875063
Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant haematological diseases. Despite continuous improvements in pre- and post-transplantation procedures, the applicability of allo-HSCT is limited by life-threatening...
7.
Kerep A, Olivieri A, Schoemans H, Lawitschka A, Halter J, Pulanic D, et al.
Bone Marrow Transplant
. 2022 Oct;
58(1):68-71.
PMID: 36229646
Chronic graft versus host disease (cGVHD) affects patients after allogeneic hematopoietic stem cell transplantation (alloHSCT). This orphan disease poses a challenge for clinicians and researchers. The purpose of the cGVHD...
8.
Koh M, Halter J, Greinix H, Aljurf M, Worel N
Lancet Haematol
. 2022 Sep;
9(11):e803-e804.
PMID: 36156201
No abstract available.
9.
Greinix H, Ayuk F, Zeiser R
Leukemia
. 2022 Sep;
36(11):2558-2566.
PMID: 36153436
Patients with steroid-refractory graft-versus-host disease (GvHD) are known to have a poor prognosis and for decades no approved drug has been available to treat this serious condition. Although ruxolitinib, a...
10.
Worel N, Aljurf M, Anthias C, Buser A, Cody M, Fechter M, et al.
Lancet Haematol
. 2022 Jul;
9(8):e605-e614.
PMID: 35901845
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem cell transplantations (HSCT) remains increasingly important, particularly because of the growing use of haploidentical HSCT. Compared...